Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELG^) closed at $0.12 on October 23, 2026, up 2.8% from the previous close, on volume of 35,470 shares (30-day average 10,863).
Data as of October 23, 2026.
No headlines found.
No press releases found.
No news found.
Bristol-Myers Squibb Company Celegne Contingent Value Rights trades on the stock market under the symbol CELG^.
As of October 23, 2026, CELG^ stock price was flat at $0.12 with 35,470 million shares trading.
CELG^ has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, CELG^ traded as high as $.27 and as low as $.02.
CELG^ has outperformed the market in the last year with a price return of +332.6% while the SPY ETF gained +14.3%. CELG^ has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +4.5% and +3.7%, respectively, while the SPY returned +3.2% and -2.4%, respectively.
CELG^ support price is $.10 and resistance is $.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELG^ shares will trade within this expected range on the day.
